US Patent Issued to UNIVERSITE DE GENEVE on Sept. 29 for "FlmG-dependent soluble protein O-glycosylation systems in bacteria" (Swiss, French Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,442, issued on Sept. 29, was assigned to UNIVERSITE DE GENEVE (Geneva).

"FlmG-dependent soluble protein O-glycosylation systems in bacteria" was invented by Patrick Viollier (Mies, Switzerland), Silvia Ardissone (Geneva) and Nicolas Kint (Annemasse, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a polynucleotide flmG which encodes Flagellin Modification Protein (FlmG) having glycosyltransferase activity, as well as a recombinant expression vector for bacterial expression comprising a polynucleotide flmG. Also provided is a prokaryotic protein glycosylation kit for soluble O-glycosylation comprising a bacteri...